RxDoctor Payments DataLook up a doctor →

Allan Joseph, MD

Obstetrics & Gynecology · Augusta, GANPI 1407825094

Payments from drug & device makers

$161,112in general payments, 2019–2025

Across 293 payments — averaging $549.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$125K
  • Abbott$28K
  • Myovant Sciences Inc.$3K
  • Novo Nordisk$566
  • Astellas Pharma US Inc$514
  • Daiichi Sankyo Inc.$408
  • plus $3K from 38 others

What the payments were for

  • Food & beverage$5,61696%
  • Education$2484%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$161,112 in reported general payments places this provider in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.

See all obstetrics & gynecology providers in Georgia

Medicare billing

Part B allowed, 2024
$53,597
Medicare patients
209
Services billed
606

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron20$17,990
Estradiol290$8,374
ProgesteroneProgesterone, Micronized183$6,687
Liothyronine Sodium157$6,552
PremarinEstrogens, Conjugated11$4,885
Estradiol (Twice Weekly)Estradiol70$4,422
SynthroidLevothyroxine Sodium44$3,880
Estradiol Valerate12$1,263
Armour ThyroidThyroid,pork11$943
Np ThyroidThyroid,pork15$818
FyavolvNorethindrone Ac/Eth Estradiol13$660
Spironolactone58$649
Levothyroxine Sodium67$524
ValacyclovirValacyclovir Hcl17$522
Metronidazole22$440

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Astellas Pharma US IncMyrbetriq$514$17,99020 claims
PfizerPremarin$264$4,88511 claims
AbbVieSynthroid, Armour Thyroid$125,014$4,82355 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,324 obstetrics & gynecology providers in Georgia.

Other obstetrics & gynecology in Augusta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →